| Net Cash Provided by (Used in) Operating Activities |
$296,000 |
USD |
-109% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$375,000 |
USD |
66% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$1,133,000 |
USD |
-53% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
4,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
3,459,888 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,804,000 |
USD |
-218% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$13,344,000 |
USD |
31% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$39,314,000 |
USD |
7.8% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$36,356,000 |
USD |
-2.3% |
Q2 2025 |
FY 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$974,000 |
USD |
262% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$15,410,000 |
USD |
6.2% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Authorized |
100,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Unrecognized Tax Benefits |
$1,665,000 |
USD |
0% |
Q2 2025 |
FY 2025 |
| Additional Paid in Capital |
$3,634,000 |
USD |
-1.6% |
Q3 2025 |
Q1 2026 |
| Depreciation, Depletion and Amortization |
$1,656,000 |
USD |
-0.72% |
Q3 2025 |
Q1 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |